BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34737738)

  • 1. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
    Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
    Front Immunol; 2021; 12():716250. PubMed ID: 34737738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
    Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
    Mondal S; Thompson PR
    Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
    Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
    Wang Y; Chen R; Gan Y; Ying S
    Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
    Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
    Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays.
    Poulsen TBG; Damgaard D; Jørgensen MM; Senolt L; Blackburn JM; Nielsen CH; Stensballe A
    Sci Rep; 2021 Aug; 11(1):17300. PubMed ID: 34453079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
    Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14
    Okamato Y; Ghosh T; Okamoto T; Schuyler RP; Seifert J; Charry LL; Visser A; Feser M; Fleischer C; Pedrick C; August J; Moss L; Bemis EA; Norris JM; Kuhn KA; Demoruelle MK; Deane KD; Ghosh D; Holers VM; Hsieh EWY
    J Autoimmun; 2021 Feb; 117():102581. PubMed ID: 33310262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
    Curran AM; Naik P; Giles JT; Darrah E
    Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
    PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis.
    Peng T; Li B; Bi L; Zhang F
    Biomed Pharmacother; 2024 May; 174():116551. PubMed ID: 38636399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine.
    Martinez-Prat L; Palterer B; Vitiello G; Parronchi P; Robinson WH; Mahler M
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1073-1087. PubMed ID: 31524005
    [No Abstract]   [Full Text] [Related]  

  • 14. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
    Li B; Li P; Bi L
    Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage.
    Romero V; Darrah E; Andrade F
    Arthritis Rheumatol; 2020 Jun; 72(6):912-918. PubMed ID: 31876120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
    Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
    Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex.
    Petrozziello T; Mills AN; Vaine CA; Penney EB; Fernandez-Cerado C; Legarda GPA; Velasco-Andrada MS; Acuña PJ; Ang MA; Muñoz EL; Diesta CCE; Macalintal-Canlas R; Acuña-Sunshine G; Ozelius LJ; Sharma N; Bragg DC; Sadri-Vakili G
    Neurobiol Dis; 2020 Oct; 144():105032. PubMed ID: 32739252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen.
    Damgaard D; Senolt L; Nielsen MF; Pruijn GJ; Nielsen CH
    Arthritis Res Ther; 2014 Dec; 16(6):498. PubMed ID: 25475141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis.
    Makrygiannakis D; Revu S; Engström M; af Klint E; Nicholas AP; Pruijn GJ; Catrina AI
    Arthritis Res Ther; 2012 Jan; 14(1):R20. PubMed ID: 22284820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective on Protein Arginine Deiminase Activity-Bicarbonate Is a pH-Independent Regulator of Citrullination.
    Zhou Y; Mittereder N; Sims GP
    Front Immunol; 2018; 9():34. PubMed ID: 29403504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.